Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_assertion type Assertion NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_head.
- NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_assertion description "[Without correction for multiple testing, one polymorphism in GPX2 and three polymorphisms in GPX3 were associated with a significant risk reduction for rectal cancer at ? = 0.05, specifically for rectal cancers with TP53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_provenance.
- NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_assertion evidence source_evidence_literature NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_provenance.
- NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_assertion SIO_000772 22371331 NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_provenance.
- NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_assertion wasDerivedFrom befree-20150227 NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_provenance.
- NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_assertion wasGeneratedBy ECO_0000203 NP749632.RAbvbi__Z-eELn7u8jjp8_4fs5dAMgSTq43vj7a5Uzde0130_provenance.